| 摘要: |
| 目的 基于转录组学技术探讨藏药二十五味鬼臼丸(GJW)对绝经后骨质疏松症(PMOP)大鼠的基因表达及分子机制。方法 将36只3月龄SD雌性大鼠随机分为假手术组(Sham)、模型组(OVX)和GJW组,药物干预12周后取大鼠股骨,采用RNA-Seq技术进行转录组测序,并对测序结果进行GO注释和KEGG富集分析;通过RT-qPCR和Western blot验证测序结果。结果 转录组测序共筛选出190个差异基因,其中GJW组上调153个,下调690个。GO 分析表明,差异基因主要参与肌原纤维形成、B 细胞受体信号通路、线粒体翻译等生物过程,定位于免疫球蛋白复合体、线粒体蛋白复合体等细胞组分,行使免疫球蛋白受体结合等分子功能。KEGG分析发现钙信号通路、焦点粘附、ECM-受体相互作用、MAPK等通路显著富集。RT-qPCR验证结果表明,3个差异基因在GJW组显著下调,与WB结果一致。结论 转录组分析揭示藏药二十五味鬼臼丸通过调节与肌肉收缩和钙运输相关的基因及信号通路,可能改善PMOP大鼠的骨骼结构与新陈代谢,这为PMOP的临床诊断提供潜在生物标志物。 |
| 关键词: 绝经后骨质疏松症 藏药二十五味鬼臼丸 钙信号通路 转录组学 |
| DOI:10.13506/j.cnki.jpr.2025.12.005 |
| 基金项目:青海省科技计划项目(No.2023-ZJ-783);青海大学青年科研基金项目(No.2023-QYY-1);青海大学医学部中青年科研基金项目(No.2023-kyy-7) |
|
Publication Date:December 25, 2025
|
|
| Exploration on the mechanism of Tibetan Medicine Ershiwu Wei Guijiu Pill in preventing postmenopausal osteoporosis based on transcriptomics |
| LI Changxing1,YU Yao2,ZHANG Lixue3,MA Lina1,YANG Aiping4 |
| (1. Department of Basic Medical Science, Qinghai University Medical College,Xining 810016, China; 2. Xinjiang Hetian College, Hetian 848000, China; 3. Medical Institute of Northwest Minzu University, Lanzhou 730030,China; 4. Qinghai Red Cross Hospital, Xining 810099, China) |
| Abstract: |
| Objective Based on transcriptomics technology, this study explores the gene expression and molecular mechanism of the Tibetan medicine Ershiwu Wei Guijiu Pill (GJW) in rats with postmenopausal osteoporosis (PMOP). Methods Thirty-six 3-month-old Sprague-Dawley (SD) female rats were randomly assigned to Sham, OVX (model), and GJW treatment groups. After 12 weeks of intervention, the femurs were harvested for RNA sequencing (RNA-Seq). The sequencing data were analyzed using Gene Ontology (GO) annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Real-time quantitative PCR (RT-qPCR) and Western blotting were employed to validate the transcriptomic results.Results A total of 190 differentially expressed genes (DEGs) were identified, with 153 genes upregulated and 690 genes downregulated in the GJW group. GO analysis demonstrated that the differentially expressed genes were mainly involved in biological processes such as myofibril formation, B-cell receptor signaling pathway, and mitochondrial translation, were localized in cellular components like immunoglobulin complexes and mitochondrial protein complexes, and exerted molecular functions like immunoglobulin receptor binding. KEGG pathway analysis identified significant enrichment in pathways related to calcium signaling, focal adhesion, ECM-receptor interactions, and MAPK signaling. RT-qPCR results confirmed the downregulation of three specific DEGs in the GJW group, and Western blot results corroborated these findings. Conclusion Transcriptomic analysis indicated that the Ershiwu Wei Guijiu Pill regulates genes and signaling pathways associated with muscle contraction and calcium transport, potentially improving skeletal structure and metabolism in PMOP rats. These findings suggest potential biomarkers for the clinical diagnosis of PMOP. |
| Key words: Postmenopausal osteoporosis Tibetan Medicine Ershiwu Wei Guijiu Pill Calcium signaling pathway Transcriptomics |